Valuation: BioElectronics Corporation

Market Cap 1.24Cr 1.08Cr 1.02Cr 92.36L 1.73Cr 118.53Cr 1.74Cr 12Cr 4.7Cr 60Cr 4.64Cr 4.54Cr 193.9Cr P/E 2020
-26.5x
P/E 2021 -95.5x
Enterprise Value 2.57Cr 2.24Cr 2.12Cr 1.92Cr 3.6Cr 246.55Cr 3.61Cr 25Cr 9.78Cr 125.35Cr 9.65Cr 9.44Cr 403.32Cr EV / Sales 2020
53.6x
EV / Sales 2021 24.2x
Free-Float
100%
Yield 2020 *
-
Yield 2021 -
1 week+14.29%
Current month+48.15%
1 month+33.33%
3 months+14.29%
6 months+33.33%
1 week 0
Extreme 0.0003
0
1 month 0
Extreme 0.0002
0
Current year 0
Extreme 0.0002
0
1 year 0
Extreme 0.0001
0
3 years 0
Extreme 0.0001
0
5 years 0
Extreme 0.0001
0
10 years 0
Extreme 0.0001
0.01
Manager TitleAgeSince
Chief Executive Officer - 15/11/2019
Corporate Officer/Principal - -
Director TitleAgeSince
Director/Board Member - 15/11/2019
Chairman 85 15/06/2020
Director/Board Member - 03/12/2024
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+14.29%+300.00%-.--% 98.82L
-1.04%+6.83%+35.41%+28.31% 24TCr
-0.32%+5.83%+8.47%-16.53% 15TCr
+2.55%+6.55%-9.75%+31.91% 14TCr
-0.48%+0.84%-55.88%-18.23% 6.28TCr
+0.01%+4.61%+18.39%+21.00% 5.09TCr
-1.69%-1.20%-20.18%-16.57% 4.82TCr
+0.08%+6.49%+22.61%+38.85% 4.41TCr
-1.88%+3.25%+37.62%+54.22% 4.14TCr
-2.27%+16.07%+132.57%+68.26% 3.62TCr
Average -0.50%+5.27%+46.93%+19.12% 8.12TCr
Weighted average by Cap. -0.26%+5.76%+15.07%+17.66%

Financials

2020 2021
Net sales 8L 7L 7L 6L 11.62L 7.96Cr 11.67L 81.82L 31.57L 4.05Cr 31.16L 30.47L 13Cr 16.09L 14.03L 13.25L 12.03L 22.55L 15Cr 22.64L 1.59Cr 61.26L 7.85Cr 60.46L 59.12L 25Cr
Net income -11.6L -10.11L -10L -9L -16.25L -11Cr -16.31L -1.14Cr -44.14L -5.66Cr -43.56L -42.6L -18Cr -3L -3L -2L -2L -4L -2.78Cr -4L -28.58L -11.03L -1.41Cr -10.89L -10.65L -4.55Cr
Net Debt 1.31Cr 1.14Cr 1.08Cr 97.71L 1.83Cr 125.39Cr 1.84Cr 13Cr 4.97Cr 64Cr 4.91Cr 4.8Cr 205.13Cr 1.33Cr 1.16Cr 1.1Cr 99.75L 1.87Cr 128.02Cr 1.88Cr 13Cr 5.08Cr 65Cr 5.01Cr 4.9Cr 209.43Cr
Logo BioElectronics Corporation
BioElectronics Corporation is an electroceutical company, which develops wearable, neuromodulation devices to safely mitigate neurological diseases. Its pulsed shortwave therapy technology (PSWT) uses low-power pulsed electromagnetic fields to regulate electrical activity of the nervous system. The Company’s product line includes ActiPatch Musculoskeletal Pain Therapy, and RecoveryRx Post-operative and Chronic Wounds Therapy, which are sold by or on the order of medical professionals. PSWT is a non-invasive electromagnetic therapy designed to reduce pain and enhance life in patients with chronic musculoskeletal conditions. PSWT has no systemic side effects and can be self-administered at home. The ActiPatch product provides advanced long-lasting pain relief using Electromagnetic Pulse Therapy and works great for back pain, knee pain, muscle & joint pain, arthritis, sciatica, fibromyalgia, strains, sprains and more.
Employees
9
Date Price Change Volume
18/26/18 $0.000400 -.--% 43,50,000
17/26/17 $0.000400 +14.29% 28,20,500
16/26/16 $0.000350 +6.06% 4,00,000
15/26/15 $0.000330 -5.71% 18,05,350
14/26/14 $0.000350 -.--% 28,42,500
  1. Stock Market
  2. Stocks
  3. BIEL Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!